bromodichloromethane has been researched along with Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhasson, F; Chandrashekaran, V; Chatterjee, S; Das, S; Dattaroy, D; Schnellmann, RG; Seth, RK | 1 |
| Aida, Y; Mitsumori, K; Onodera, H; Takahashi, M; Yasuhara, K | 1 |
2 other study(ies) available for bromodichloromethane and Fibrosis
| Article | Year |
|---|---|
NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.
Topics: Animals; Antigens, CD1d; Cell Death; Cell Line; Cell Proliferation; Cellular Microenvironment; Cytochrome P-450 CYP2E1; Diet, High-Fat; Disease Models, Animal; Fibrosis; HMGB1 Protein; Inflammation Mediators; Kidney Diseases; Kidney Tubules, Proximal; Lipid Peroxidation; Liver; Male; Mesangial Cells; Mice, Inbred C57BL; Mice, Knockout; Natural Killer T-Cells; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Toll-Like Receptor 4; Transforming Growth Factor beta; Trihalomethanes | 2016 |
[Cell proliferative activities of cholangiofibrosis induced in rats treated with bromodichloromethane].
Topics: Administration, Oral; Animals; Bile Duct Diseases; Bile Ducts; Cell Division; Disease Progression; Female; Fibrosis; Hydrocarbons, Halogenated; Liver; Male; Nucleolus Organizer Region; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Time Factors; Trihalomethanes | 1995 |